Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis

Journal of Gastroenterology

Volumn 45, Issue 5, 2010, Pages 554-559

  Hayashi, Hiromitsu ^a   Beppu, Toru ^a   Okabe, Kazutoshi ^b   Masuda, Toshiro ^a   Okabe, Hirohisa ^a   Ishiko, Takatoshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NTT West Kyushu Hospital   (Japan)

Author keywords

Infarcted splenic volume; Liver cirrhosis; Noninfarcted splenic volume; Partial splenic embolization; Splenic infarction ratio

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLEEN INFARCTION; SPLEEN SIZE; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AGED; COHORT STUDIES; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYPERSPLENISM; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ORGAN SIZE; PLATELET COUNT; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SPLENECTOMY; SPLENIC INFARCTION; THROMBOCYTOPENIA;

EID: 77953325674     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0185-9     Document Type: Article

References (15)

1. H Noguchi K Hirai Y Aoki K Sakata K Tanikawa 1995 Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism Hepatology 22 1682 1688 10.1002/hep.1840220611 1:STN:280:DyaK28%2FovVyhsA%3D%3D 7489974
2. B Sangro I Bilbao I Herrero C Corella J Longo O Beloqui, et al. 1993 Partial splenic embolization for the treatment of hypersplenism in cirrhosis Hepatology 18 309 314 10.1002/hep.1840180214 1:STN:280:DyaK3szjvFOgsg%3D%3D 8340060
3. MF Mozes DG Spigos R Pollak R Abejo DG Pavel WS Tan, et al. 1984 Partial splenic embolization, an alternative to splenectomy-results of a prospective, randomized study Surgery 96 694 702 1:STN:280:DyaL2M%2FhslWhug%3D%3D 6385316
4. G N'Kontchou O Seror V Bourcier D Mohand Y Ajavon L Castera, et al. 2005 Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients Eur J Gastroenterol Hepatol 17 179 184 10.1097/00042737-200502000-00008 15674095 (Pubitemid 40349531)
5. K Hirai Y Kawazoe K Yamashita M Kumagai M Tanaka T Sakai, et al. 1986 Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis Hepatogastroenterology 33 105 108 1:STN:280:DyaL28zgt1eitQ%3D%3D 3017829
6. T Tajiri M Onda H Yoshida Y Mamada N Taniai T Kumazaki 2002 Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis Hepatogastroenterology 49 1445 1448 12239963
7. H Yoshida Y Mamada N Taniai T Tajiri 2008 Partial splenic embolization Hepatol Res 38 225 233 10.1111/j.1872-034X.2007.00302.x 18034810 (Pubitemid 351193950)
8. JR Foruny J Blazquez A Moreno R Barcena L Gil-Grande C Quereda, et al. 2005 Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization Eur J Gastroenterol Hepatol 17 1157 1164 10.1097/00042737-200511000-00002 1:CAS:528:DC%2BD2MXhtVymt7fF 16215426 (Pubitemid 41527431)
9. B Palsson H Verbaan 2005 Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection Eur J Gastroenterol Hepatol 17 1153 1155 10.1097/00042737-200511000-00001 16215425 (Pubitemid 41527430)
10. N Sohara H Takagi S Kakizaki K Sato M Mori 2006 The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia Transpl Int 19 255 257 10.1111/j.1432-2277.2006.00263.x 16441778
11. H Hayashi T Beppu T Masuda T Mizumoto M Takahashi T Ishiko, et al. 2007 Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients J Gastroenterol Hepatol 22 1638 1642 10.1111/j.1440-1746.2007.05090.x 1:CAS:528:DC%2BD2sXht1yltbnI 17683504 (Pubitemid 47383343)
12. H Hayashi T Beppu K Okabe T Masuda H Okabe H Baba 2008 Risk factors for complications after partial splenic embolization for liver cirrhosis Br J Surg 95 744 750 10.1002/bjs.6081 1:STN:280:DC%2BD1c3pt1egsw%3D%3D 18412294
13. A Alwmark S Bengmark P Gullstrand B Joelsson A Lunderquist T Owman 1982 Evaluation of splenic embolization in patients with portal hypertension and hypersplenism Ann Surg 196 518 524 10.1097/00000658-198211000-00003 1:STN:280:DyaL3s%2FitFCgtQ%3D%3D 7125739
14. C Hezode N Forestier G Dusheiko P Ferenci S Pol T Goeser, et al. 2009 Telaprevir and peginterferon with or without ribavirin for chronic HCV infection N Engl J Med 360 1839 1850 10.1056/NEJMoa0807650 1:CAS:528:DC%2BD1MXlsVSlurg%3D 19403903
15. JG McHutchison GT Everson SC Gordon IM Jacobson M Sulkowski R Kauffman, et al. 2009 Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection N Engl J Med 360 1827 1838 10.1056/NEJMoa0806104 1:CAS:528:DC%2BD1MXlsVGmtrc%3D 19403902